Clinical Trial Update: A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis. [Phase 2]

View source ↗

Summary

A Phase 2 long-term safety and efficacy study evaluating CM512 in Atopic Dermatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• CM512

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Atopic Dermatitis (AD) | Phase 2 | Status: RECRUITING